The politics of blood : ethics, innovation, and the regulation of risk / Anne-Maree Farrell.
By: Farrell, Anne-Maree.
Cambridge ; New York : Cambridge University Press, 2012Description: xviii, 264 p. ; 24 cm.ISBN: 9780521193184 (hardback).Subject(s): Blood banks -- Government policy | Blood products -- Safety measures | Blood -- Moral and ethical aspects | Blood -- Social measures | LAW / Medical Law & LegislationGenre/Form: Print books.DDC classification: 362.17/84| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RM172 .F37 2012 (Browse shelf) | Available | AU0000000001832 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
|
|
|
|
|
|
|
||
| RM171 .T683 2019 Transfusion medicine and hemostasis : clinical and laboratory aspects / | RM171 .T772 2015 Transfusion update / | RM172 .B54 2017 Basic & applied concepts of blood banking and transfusion practices / | RM172 .F37 2012 The politics of blood : ethics, innovation, and the regulation of risk / | RM172 .M39 2023 Blood money : the story of life, death, and profit inside America's blood industry / | RM172 .M62 2019 Modern blood banking & transfusion practices / | RM182 .P76 2012 Procedures in phlebotomy / |
Includes bibliographical references (p. 230-256) and index.
Machine generated contents note: 1. Introduction; 2. The governance of the blood system; 3. Revisiting the gift relationship; 4. Professional beliefs and scientific expertise; 5. Risk and innovation; 6. The rise of the recipient; 7. The politics of precaution; 8. Regulating risk; 9. Conclusion.
"This book examines the relationship between politics, ethics and law in risk governance involving multi-valued human biological materials, such as blood. HIV blood contamination episodes in the USA, England and France are used to examine the emergence of and the consequences resulting from the politicization of risk. The emergence of the phenomenon is examined through a focus on the role of the gift relationship in blood donation, as well as scientific expertise and innovation in risk governance processes involving the blood system. Its consequences are examined through an analysis of legal action taken by aggrieved patient groups, in addition to a critique of the increased use of precautionary and regulatory strategies in dealing with emerging risks to blood safety"--